Innovative payers are starting to look differently at how they build their pharmacy network, using a bottom-up approach to network design.
Access-based network design is an approach that can result in a significant reduction in prescription drug costs while ensuring that members maintain access to a network pharmacy. While the exact process for building an access-based network can vary based on a state's any-willing-provider laws and whether or not the plan is subject to such laws under ERISA, the basic approach follows a few principles:
Set an access standard. Quantify what access standard you want to provide for your members. For example, you may decide that you want to set a standard of 90% of your members living within six miles of a network pharmacy. Once you have quantified this access standard, your objective is to minimize costs while ensuring that the standard is achieved.
Define the prize. Let pharmacies know the number of pharmacies expected in the network. Ensure that pharmacies know their downside risk by basing reimbursement on effective rate guarantees or a cost-plus pricing methodology. By understanding downside risk, pharmacies can be more aggressive in their pricing.
Compete. Have pharmacies compete against each other to get into the network. Allow pharmacies to submit a second, more aggressive bid in order to be a preferred pharmacy that is granted a small copay advantage versus other pharmacies in the network.
Communicate. Announce the network and let members know that they have the option of lower copays at the preferred pharmacies in the network.
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Omega-3s For Dry Eye Disease? Not the Answer According to This Study
May 17th 2024Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators reported results from a randomized clinical trial this week in JAMA Ophthalmology tthat showed no benefit.
Read More